Michiko Akiyama

Antinol® Latest Studies

Sorted by recent

What’s better than fun? Double the fun! That’s exactly what 22Fun delivers with its incredible mix of games and opportunities. Whether you’re spinning the reels on slots or trying your hand at a live casino table, 22fun guarantees non-stop entertainment. This platform knows how to keep players smiling with its engaging design and rewarding features. Why just play when you can truly have fun with every bet?

Filter Studies by Smart Tags

Bone & JointCardiovascularCase Study & ProceedingCatDogEAB 277™EfficacyExotic PetImmunologyNeuro & BehaviorOphthalmologyOralRabbitRenalRespiratoryRodentSafetySkinUTI

Smart Search

Report Clinical Results of Feline Patients with Chronic Kidney Disease (CKD) that received PCSO-524® Vol.10 (2019 February)

Vetz Petz® Information Letter Vol.10 (2019 February)
Authors:
Michiko Akiyama

Chronic Kidney Disease in cat(2) treated with Antinol®

Mongrel Cat, 7 years old was admitted to Maizuru Animal Medical Center, Kidney disease was observed.

Overview: Patient was repeatedly hospitalised for treatment of CKD. But two weeks after Antinol® was added to treatment regimen, decrease in BUN, Are, and P level as well as improvement of appetite and activity was observed.

(Addition of Antinol® to treatment: 1st 2 weeks; 2 caps / day, orally. Continued with 1 caps / day, orally for 1 week. Increased dose in the 4th week to 2 caps / day, orally since appetite decreased.)

. . . VIEW

. . . VIEW
CatRenal

Report Clinical Results of Feline Patients with Chronic Kidney Disease (CKD) that received PCSO-524® Vol.9 (2018 September)

Vetz Petz® Information Letter Vol.9 (2018 September)
Authors:
Michiko Akiyama

Chronic Kidney Disease in cat(1) treated with Antinol®

Mongrel Cat, 7 years old was admitted to Maizuru Animal Medical Center, patient was diagnosed with CKD

Overview: Patient was not responding to treatment but decrease in BUN and Creatinine (Are) levels were observed after Antinol® was added to treatment regimen.

(Addition of Antinol® to treatment: 1st 2 weeks; 2 caps / day orally. Continued with 1 caps / day orally.)

. . . VIEW

. . . VIEW

Updated Study Topics

New researches and publications related to PCSO-524® and its result in clnical test submitted by veterinarians on the global conferences every year and the data keeps growing with more studies conducted

 

Discover More Studies
Click to see the library